Heart rhythm

publication venue for

2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure. 2023
Chronic Wireless Communication Between Dual-Chamber Leadless Pacemaker Devices. 2024
Cardiac Implantable Electronic Device Patient Follow-Up: Assessment of U.S. Practice. 2024
Implant Techniques for a Helix-Fixation Dual-Chamber Leadless Pacemaker. 2024
Real-Time Analysis of Conduction Disturbances During TAVR With the CARA Monitor. 2024
HRS Policy Statement on Catheter Ablation of Atrial Fibrillation. 2024
Completely Wireless: First Concomitant Dual Chamber Leadless Pacemaker and Subcutaneous Defibrillator Implant. 2024
Left Bundle Branch Area Pacing using a Stylet-Driven, Retractable-Helix Lead: Short Term Results from a Prospective, Multicenter IDE Trial (The BIO-CONDUCT Study). 2024
Six-month Electrical Performance of the First Dual-Chamber Leadless Pacemaker. 2024
Heart Rhythm Society's survey assessing same-day discharge after electrophysiology procedures and implementation in ambulatory surgical centers. 2024
Post-mortem examination of a dual chamber leadless pacemaker system: implications for chronic atrial leadless pacemaker removal. 2024
Dual-Chamber Leadless Pacing: Atrioventricular Synchrony in Preclinical Models of Normal or Blocked Atrioventricular Conduction. 2023
Impact of reductions in Medicare reimbursement for cardiac ablation in the United States: Heart Rhythm Society's follow-up survey. 2023
Stellate ganglion instrumentation for pharmacological blockade, nerve recording, and stimulation in patients with ventricular arrhythmias: Preliminary experience.. 20. 2023
Pre-clinical Evaluation of a Third Generation Absorbable Antibacterial Envelope. 2023
Heart Rhythm Society Policy Statement Update: Recommendations on the role of industry-employed allied professionals.. 20. 2022
Re-Valuing Ablation Therapy: History, Recent Developments, and Future H eart Rhythm Society Strategy. 2022
Heart Rhythm Society's Survey Assessing the Impact of Reductions in Medicare Reimbursement for Cardiac Ablation in the United States. 2022
Trends in implantable cardioverter-defibrillator programming practices and its impact on therapies: Insights from a North American Remote Monitoring Registry 2007-2018. 2021
Reappraisal of electrocardiographic criteria for localization of idiopathic outflow region ventricular arrhythmias. 2021
Venous anatomy of the left ventricular summit: Therapeutic implications for ethanol infusion.. 18. 2021
Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: A secondary analysis of the VENUS randomized clinical trial.. 18. 2021
Double-balloon technique for retrograde venous ethanol ablation of ventricular arrhythmias in the absence of suitable intramural veins.. 17. 2020
HRS White Paper on interoperability of data from cardiac implantable electronic devices (CIEDs).. 16. 2019
Transparent sharing of digital health data: A call to action.. 16. 2019
Left atrial appendage closure with the Watchman device using intracardiac vs transesophageal echocardiography: Procedural and cost considerations.. 16. 2019
Cardiorenal status using amino-terminal pro-brain natriuretic peptide and cystatin C on cardiac resynchronization therapy outcomes: From the BIOCRT Study.. 16. 2018
Impact of physiologic pacing versus right ventricular pacing among patients with left ventricular ejection fraction greater than 35%: A systematic review for the 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.. 16. 2018
Left atrial thrombus and dense spontaneous echocardiographic contrast in patients on continuous direct oral anticoagulant therapy undergoing catheter ablation of atrial fibrillation: Comparison of dabigatran, rivaroxaban, and apixaban.. 15. 2018
Utility of dual-source computed tomography in cardiac resynchronization therapy-DIRECT study.. 15. 2018
Techniques for successful early retrieval of the Micra transcatheter pacing system: A worldwide experience.. 15. 2018
Impact of institutional procedural volume on inhospital outcomes after cardiac resynchronization therapy device implantation: US national database 2003-2011.. 14. 2017
2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry.. 14. 2017
Fluoroless catheter ablation of atrial fibrillation.. 14. 2017
Trends and outcomes of cardiac resynchronization therapy upgrade procedures: A comparative analysis using a United States National Database 2003-2013.. 14. 2017
Albuminuria, kidney function, and sudden cardiac death: Findings from The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.. 14. 2016
Validation of device algorithm to differentiate pacemaker-mediated tachycardia from tachycardia due to atrial tracking.. 13. 2016
Strategies for phrenic nerve preservation during ablation of inappropriate sinus tachycardia.. 13. 2016
Monomorphic ventricular tachycardia in patients with Brugada syndrome: A multicenter retrospective study.. 13. 2015
HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices.. 12. 2015
Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation.. 12. 2015
Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers.. 11. 2014
Multicenter study on acute and long-term safety and efficacy of percutaneous left atrial appendage closure using an epicardial suture snaring device.. 11. 2014
Coronary sinus biomarker sampling compared to peripheral venous blood for predicting outcomes in patients with severe heart failure undergoing cardiac resynchronization therapy: the BIOCRT study.. 11. 2014
Adenosine-insensitive right ventricular tachycardia: novel variant of idiopathic outflow tract tachycardia.. 11. 2014
Multicenter experience with extraction of the Riata/Riata ST ICD lead.. 11. 2014
The effects of LAA ligation on LAA electrical activity.. 11. 2014
FGF12 is a candidate Brugada syndrome locus.. 10. 2013
Mechanisms, predictors, and trends of electrical failure of Riata leads.. 10. 2013
Objective quality assessment of atrial fibrillation ablation: a novel scoring system.. 10. 2013
Ethanol infusion in the vein of Marshall facilitates mitral isthmus ablation.. 9. 2012
Racial differences in sudden cardiac death among hypertensive patients during antihypertensive therapy: the LIFE study.. 9. 2011
Robotic catheter ablation of left ventricular tachycardia: initial experience.. 8. 2011
Electrophysiologic properties of para-Hisian atrial tachycardia.. 8. 2011
Pinning down the CaMKII targets in the L-type Ca(2+) channel: an essential step in defining CaMKII regulation.. 8. 2010
The future of fellowship training in clinical cardiac electrophysiology: Program directors' perspective 2008.. 6. 2009
Ethanol infusion in the vein of Marshall: Adjunctive effects during ablation of atrial fibrillation.. 6. 2009
Instability in action potential morphology underlies phase 2 reentry: a mathematical modeling study.. 6. 2009
Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study.. 6. 2009
Mechanisms of focal ventricular tachycardia in humans.. 6. 2009
Effect of pulmonary vein isolation on the distribution of complex fractionated electrograms in humans.. 6. 2008
Multidetector row computed tomography for identification of left atrial appendage filling defects in patients undergoing pulmonary vein isolation for treatment of atrial fibrillation: comparison with transesophageal echocardiography.. 5. 2007
Effect of bundle branch block on microvolt T-wave alternans and electrophysiologic testing in patients with ischemic cardiomyopathy.. 4. 2007
Percutaneous intrapericardial echocardiography during catheter ablation: a feasibility study.. 3. 2006
How to interpret electroanatomic maps.. 3. 2006
Circadian variations of stellate ganglion nerve activity in ambulatory dogs.. 3. 2006
Value of high-density endocardial and epicardial mapping for catheter ablation of hemodynamically unstable ventricular tachycardia.. 3. 2006
Impedance monitoring during catheter ablation of atrial fibrillation.. 2. 2005
Three-dimensional identification of the esophagus during ablation of atrial fibrillation.. 2. 2005
Significance of adenosine-induced atrioventricular block in patients with unexplained syncope.. 1. 2004
Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death.. 1. 2004
Percutaneous epicardial mapping during ablation of difficult accessory pathways as an alternative to cardiac surgery.. 1. 2004
Author's reply to Ask Not If, But Which Ablations May Be Performed In the ASC! 2024
Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013. 2014
The complex decision of leadless cardiac pacing: How to choose among the expanding options? 2024
Synergistic Effects of Cation Supplementation for Pharmacologic Conversion of Atrial Fibrillation. 2023
Electrogram Signatures in Substrate Mapping for Ventricular Tachycardia: Does Phenomenology Enhance Clarity? 2022
The search for links between atrial fibrillation pathogenesis and ablation outcomes.. 13. 2016
Connecting the dots from radiographic to electrophysiologic substrate in hypertrophic cardiomyopathy.. 12. 2015
Simplified pulmonary vein isolation: are we there yet?. 11. 2013
Eastern promises: Additive role of metabolic syndrome for thromboembolic risk stratification in Taiwanese atrial fibrillation patients.. 11. 2013
Public reporting of cardiovascular care: an opportunity to shape the future.. 10. 2013
Guidelines for implantation of primary prevention defibrillators: who is listening?. 9. 2012
Expanding the role of statins in postoperative atrial fibrillation.. 9. 2011
Action potential voltage alternans: an indicator of calcium handling dysfunction during heart failure?. 7. 2010
Pulmonary vein reconnection after cryoballoon ablation: back to the drawing board.. 7. 2009
Improving the utility of T-wave alternans by quantifying its relationship to underlying action-potential duration alternans.. 6. 2009
Implantable cardioverter-defibrillator detection of repolarization alternans: uncovering a marker of electrical instability.. 3. 2006
Ablation of postinfarction ventricular tachycardia: virtual or reality?. 2. 2005
Electrophysiologic and Cardiovascular Manifestations of Duchenne and Becker Muscular Dystrophies. 2024
Management of Anesthesia for Procedures in the Cardiac Electrophysiology Laboratory. 2024
Left atrial appendage occlusion using intracardiac echocardiography. 2020
SCAI/HRS expert consensus statement on transcatheter left atrial appendage closure. 2023
Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment. 2020

VIVO Weill Cornell Medical College

Heart rhythm Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)